突发性聋伴良性阵发性位置性眩晕患者的预后观察
发布时间：2018-09-07 07:29
【摘要】：目的:探讨突聋伴良性阵发性位置性眩晕(BPPV)患者的预后。方法:252例突聋患者中96例伴眩晕,加行眼震电图检查。将全部患者分为3组:突聋不伴眩晕组156例,突聋伴非BPPV眩晕组70例,突聋伴BPPV组26例。全部患者经静脉滴注尿激酶20万U、10万U各3d,同时静脉滴注银杏叶制剂及维生素B6,肌肉注射维生素B1、B12,治疗疗程2周。眼震电图行变位试验确诊为BPPV的26例患者进行手法复位治疗。结果:突聋伴BPPV组眩晕症状均治愈;在治疗后听力改善显效率上,突聋不伴眩晕组与突聋伴BPPV组无明显差异,但突聋伴非BPPV眩晕组明显低于其他2组。结论:突聋伴BPPV患者在听力及眩晕两个症状方面的预后相对良好。
[Abstract]:Objective: to investigate the prognosis of sudden deafness with benign paroxysmal positional vertigo (BPPV). Methods among 252 cases of sudden deafness, 96 cases were accompanied with vertigo. All the patients were divided into 3 groups: 156 cases of sudden deafness without vertigo, 70 cases of sudden deafness with non BPPV vertigo and 26 cases of sudden deafness with BPPV. All patients were treated with intravenous infusion of urokinase 200000 U, 100000 U for 3 days, intravenous infusion of ginkgo biloba and vitamin B6, intramuscular injection of vitamin B1 and B12 for 2 weeks. Twenty-six patients with BPPV diagnosed by ENG were treated with manual reduction. Results: the vertigo symptoms of sudden deafness and BPPV group were all cured, and there was no significant difference between sudden deafness without vertigo group and sudden deafness with BPPV group, but the rate of sudden deafness with non-BPPV vertigo group was significantly lower than that of other two groups. Conclusion: the prognosis of hearing and vertigo in patients with sudden deafness and BPPV is relatively good.
【作者单位】： 西安医学院附属医院耳鼻咽喉科;西安交通大学第二附属医院耳鼻咽喉头颈外科;
【基金】：陕西省国际科技合作重点项目资助(No:2013KW-28)
【分类号】：R764.43
，
本文编号：2227611
[Abstract]:Objective: to investigate the prognosis of sudden deafness with benign paroxysmal positional vertigo (BPPV). Methods among 252 cases of sudden deafness, 96 cases were accompanied with vertigo. All the patients were divided into 3 groups: 156 cases of sudden deafness without vertigo, 70 cases of sudden deafness with non BPPV vertigo and 26 cases of sudden deafness with BPPV. All patients were treated with intravenous infusion of urokinase 200000 U, 100000 U for 3 days, intravenous infusion of ginkgo biloba and vitamin B6, intramuscular injection of vitamin B1 and B12 for 2 weeks. Twenty-six patients with BPPV diagnosed by ENG were treated with manual reduction. Results: the vertigo symptoms of sudden deafness and BPPV group were all cured, and there was no significant difference between sudden deafness without vertigo group and sudden deafness with BPPV group, but the rate of sudden deafness with non-BPPV vertigo group was significantly lower than that of other two groups. Conclusion: the prognosis of hearing and vertigo in patients with sudden deafness and BPPV is relatively good.
【作者单位】： 西安医学院附属医院耳鼻咽喉科;西安交通大学第二附属医院耳鼻咽喉头颈外科;
【基金】：陕西省国际科技合作重点项目资助(No:2013KW-28)
【分类号】：R764.43
，
本文编号：2227611
本文链接：https://www.wllwen.com/yixuelunwen/yank/2227611.html
最近更新
教材专著
